BHATT NAILESH purchased 436.1% of their position (25K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $5.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/18/2023ACC: 0001493152-23-018038
Director
Since Apr 2020
+25K
Net shares
Net buyer
$5.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$0.23
Trade value
$5.80K
% of position
436.1%
5/17/2023
5.73K→30.73K
Total
Net shares
+25K
Net value
$5.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/17/2023 | P · Purchase | +25K | $0.23 | $5.80K | 436.1% | 5.73K | 30.73K |
| Total | +25K | $5.80K | ||||||
Derivative Transactions0
No derivative transactions reported